Objectives: The aim of this study was to investigate left ventricular (LV) function reserve in hypertrophic cardiomyopathy (HCM) patients with and without cardiac troponin gene mutations before transition to the dilated phase.
Methods: LV ejection fraction (EF) was continuously evaluated in 52 patients with non-obstructive HCM during supine ergometer exercise using radionuclide ventricular function monitoring with a cadmium telluride detector (VEST). On the basis of genetic analysis, patients were divided into two groups: 10 with cardiac troponin gene mutations (group A) and 42 without these gene mutations (group B).
Results: Exercise duration, peak exercise load, and heart rate during exercise did not differ between the two groups. The differences from baseline to peak exercise of the LV end-diastolic volume decreased similarly in the two groups. In contrast, the difference of the LV end-systolic volume in group A increased significantly compared with group B (17.7% (SD 12.7%) vs 3.4% (SD 13.2%); p = 0.0031). Consequently, the difference of LVEF in group A decreased significantly in contrast with group B (–14.1% (SD 11.1%) vs –1.2% (SD 11.7%); p = 0.0025). Additionally, the changes in LVEF and stroke volume decreased significantly more in group A than in group B (–22.2% (SD 18.6%) vs –1.1% (SD 17.8%); p = 0.0017 and –12.9% (SD 21.7%) vs 12.3% (SD 24.4%); p = 0.0042, respectively).
Conclusions: These results suggest that HCM patients with cardiac troponin gene mutations may display exercise-induced LV systolic dysfunction more frequently than HCM patients without this abnormality.
Statistics from Altmetric.com
Competing interests: None declared.